U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday. She said Kennedy insisted she commit to pre-approving recommendations from the CDC’s vaccine advisory board and fire staff overseeing vaccine policy. Monarez refused, and days later, President Donald Trump dismissed her after just 29 days in the role.
Monarez, a microbiologist and immunologist with nearly two decades of federal service, was the first CDC director confirmed by the Senate. She testified that Kennedy told her “there was no science” supporting the current vaccine schedule and that if she did not comply, she should resign. He also barred her from speaking with Senators. Kennedy, however, denied demanding pre-approval during a Senate Finance Committee hearing earlier this month.
Her ousting triggered the resignation of four senior CDC officials, who cited Kennedy’s anti-vaccine stance and misinformation. Critics, including medical professionals, have called for Kennedy to step down, warning his policies undermine public health. Senator Bill Cassidy, chair of the Senate health committee, said the firing raised questions about why someone with “unimpeachable scientific credentials” was pushed out so quickly.
Kennedy has reshaped the CDC’s vaccine advisory board, replacing all 17 members with 12 new appointees. Experts warn that upcoming votes on childhood vaccines lack the usual scientific rigor, since key work group meetings have not been held. Cassidy cautioned Americans against trusting potential changes to the vaccine schedule. Kennedy has already narrowed eligibility for COVID-19 shots and cut funding for mRNA vaccine research, deepening concerns over U.S. vaccination policy.


FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Trump Appoints Colin McDonald as Assistant Attorney General for National Fraud Enforcement
Trump Administration Sued Over Suspension of Critical Hudson River Tunnel Funding
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Ukraine-Russia Talks Yield Major POW Swap as U.S. Pushes for Path to Peace
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 



